Web Stats Provided By Google Analytics

The Raw Stem Cell News Feed

The Stem Cell Research Newswire: Comprehensive Real-Time News Feed for Stem Cell Research

Monday, March 31, 2014

Otsuka Acquires Rights to Hematological Cancer Treatment Dacogen from Eisai

Otsuka Pharmaceutical Co., Ltd. has announced an agreement with Eisai Inc. , a U.S. subsidiary of Eisai Co., Ltd. to acquire rights to the hematological cancer treatment Dacogen and to an enzyme inhibitor, E7727.

http://ift.tt/1fd9alj
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Popular Stem Cell Roundup Posts